Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Auristatin PE is a tubulin polymerization inhibitor, an anticancer agent, and a derivative of dolastatin 10.1 It inhibits tubulin polymerization (IC50< = 2.2 µM), completely inhibits the proliferation of WSU-WM Waldenström's macroglobulinemia cells at 100 pg/ml, and induces cell cycle arrest at the G2/M phase and apoptosis in the same cells at 10 pg/ml.1,2 Auristatin PE induces tumor regression in MX-1 breast cancer, LX-1 lung cancer, and WSU-WM mouse xenograft models.
WARNING This product is not for human or veterinary use.
1. Antitumor activity of TZT-
2. A new tubulin ploymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom’s macroglobulinemia xenograft model. Int. J. Oncol. 15, 367-372 (1999).